Dimerized peptide

Details for Australian Patent Application No. 2004204031 (hide)

International Classifications

Event Publications

28 July 2005 PCT application entered the National Phase

PCT publication WO2004/063217 Priority application(s): WO2004/063217

2 November 2006 Assignment before Grant

Sugiyama, Haruo; Kaisha, Chugai; Sumitomo Pharmaceuticals Company Limited The application has been assigned to Sugiyama, Haruo; Kaisha, Chugai; Dainippon Sumitomo Pharma Co., Ltd.

7 December 2006 Assignment before Grant

Haruo Sugiyama The application has been assigned to Kaisha, Chugai; Dainippon Sumitomo Pharma Co., Ltd.; International Institute of Cancer Research

4 March 2010 Application Accepted

Published as AU-B-2004204031

13 May 2010 Application for Amendment

The nature of the amendment is: Add the co-inventor Sugiyama, Haruo. Address for service in Australia - Davies Collison Cave 1 Nicholson Street Melbourne VIC 3000

13 May 2010 Alteration of Name

The name of the applicant has been altered to Kaisha, C.; Dainippon Sumitomo Pharma Co., Ltd.; International Institute of Cancer Immunology, Inc.

27 May 2010 Corrigenda

Change of Names(s) of Applicant(s), Section 104 - 2004 Under the name International Institute of Cancer Research ; Dainippon Sumitomo Pharma Co., Ltd. ; Chugai Kaisha, Application No. 2004204031, under INID (71), correct the co-applicant name from Chugai Kaisha to Chugai Seiyaku Kabushiki Kaisha

2 September 2010 Amendment Made

The nature of the amendment is: Add co-inventor Sugiyama, Haruo

9 September 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.